Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2190-2193

  Simor, Andrew E ^a,b   Louie, Marie ^a,b   Low, Donald E ^b,c   Abbott, L ^d   Blondeau, J ^e   Brown, C ^f   Hanson, S ^f   Forward, K ^g   Hoban, D ^h   Kibsey, P ⁱ   Kuhn, M ^j   Laverdiere, M ^k   Louie, T ^l   Szumski, R ^m  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Prince Edward Island   (Canada)

^e Saskatoon Health Region St Pauls Hospital   (Canada)

^f Victoria General Hospital ^*

^g QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^h HEALTH SCIENCES CENTRE   (Canada)

ⁱ ROYAL JUBILEE HOSPITAL   (Canada)

^j MONCTON HOSPITAL   (Canada)

^k MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^l Calgary General Hospital   (Canada)

^m Calgary Medical Laboratories   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; OFLOXACIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CANADA; COLONY FORMING UNIT; CONTROLLED STUDY; HEALTH SURVEY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 9544231791     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2190     Document Type: Article

References (22)

1. Applebaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Baer, M., R. Vuento, and T. Vesikari. 1995. Increase in bacteraemic pneumococcal infections in children. Lancet 345:661. (Letter.)
3. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory tract pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
4. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
5. Dixon, J. M. S., A. E. Lipinski, and M. E. P. Graham. 1977. Detection and prevalence of pneumococci with increased resistance to penicillin. Can. Med. Assoc. J. 117:1159-1161.
6. Foster, J. A., and K. L. McGowan. 1994. Rising rate of pneumococcal bacteremia at the Children's Hospital of Philadelphia. Pediatr. Infect. Dis. J. 13:1143-1144. (Letter.)
7. Friedland, I. R., and K. P. Klugman. 1992. Antibiotic-resistant pneumococcal disease in South African children. Am. J. Dis. Child. 146:920-923.
8. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
9. Hackenbeck, R., M. Tarpay, and A. Tomasz. 1980. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 17:364-371.
10. Haglund, L. A., G. R. Istre, D. A. Pickett, D. F. Welch, D. P. Fine, and the Pneumococcus Study Group. 1993. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J. Infect. Dis. 168:1532-1536.
11. Handwerger, S., and A. Tomasz. 1986. Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance. J. Infect. Dis. 153:83-89.
12. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. A. Deaver, and R. F. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333: 481-486.
13. Jetté, L. P., F. Lamothe, and the Pneumococcus Study Group. 1989. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J. Clin. Microbiol. 27:1-5.
14. Marton, A., M. Gulyas, R. Munoz, and A. Tomasz. 1991. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J. Infect. Dis. 163:542-548.
15. Mazzulli, T., A. E. Simor, R. Jaeger, S. Fuller, and D. E. Low. 1990. Comparative in vitro activities of several new fluoroquinolones and β-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 34:467-469.
16. National Committee for Clinical Laboratory Standards. 1994. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Nelson, C. T., E. O. Mason, and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13:585-589.
19. París, M. M., O. Ramilo, and G. H. McCracken, Jr. 1995. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 39:2171-2175.
20. Simor, A. E., L. Louie, J. Goodfellow, and M. Louie. 1995. Emergence of penicillin-resistant Streptococcus pneumoniae - southern Ontario, Canada, 1993-1994. Morbid. Mortal. Weekly Rep. 44:207-208.
21. Viladrich, P. F., C. Cabellos, R. Pallares, F. Tubau, J. Martínez-Lacasa, J. Liñares, and F. Gudiol. 1996. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:218-220.
22. Viladrich, P. F., F. Gudiol, J. Liñares, R. Pallarés, I. Sabaté, G. Rufi, and J. Ariza. 1991. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob. Agents Chemother. 35:2467-2472.